Unicycive Therapeutics (UNCY) Capital Expenditures (2022 - 2026)
Unicycive Therapeutics (UNCY) recorded Capital Expenditures of -$1,000 in Q2 2026, compared with $6,000 a year earlier.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Capital Expenditures (2022 - 2026) Analysis & Trends
On a TTM basis, Unicycive Therapeutics' Capital Expenditures came in at $9,000 as of Jun 30, 2026, down 86.8% year-over-year; for FY2025, it was $24,000, down 66.7% from FY2024.
- Annual Capital Expenditures has a four-year compound annual growth rate of -4.6% (FY2021 to FY2025).
- Across earlier years, Capital Expenditures came in at $72,000 in FY2024 (+500.0%), $12,000 in FY2023 (+500.0%), $2,000 in FY2022 (-93.1%) and $29,000 in FY2021.
- The Q2 2026 figure is the lowest quarterly Capital Expenditures in data going back to Q1 2022.
- On a year-over-year basis, Capital Expenditures rose in 1 of the last four quarters, with an average decline of 11.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.05 Bn | 1,098.63 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 635.34 Bn | 555.20 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 504.85 Bn | 477.96 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 358.37 Bn | 312.75 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 290.48 Bn | 254.47 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 265.13 Bn | 238.81 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.92 Bn | 193.32 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 194.98 Bn | 169.17 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 171.45 Bn | 118.10 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Unicycive Therapeutics | 103.77 Mn | -96.21 Mn | - | -1,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,000.00 |
| Mar 31, 2026 | 8,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 6,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 24,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Mar 31, 2024 | 6,000.00 |
| Mar 31, 2022 | 2,000.00 |
API Access
Unicycive Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();